Cargando…
Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer
Gastric cancer (GC) with hepatic metastasis remains a fatal disease. Global expression profiling was conducted using tissues from patients who had GC with synchronous hepatic metastasis, and major facilitator superfamily domain containing 4 (MFSD4) was identified as a candidate biomarker for hepatic...
Autores principales: | Kanda, Mitsuro, Shimizu, Dai, Tanaka, Haruyoshi, Shibata, Masahiro, Iwata, Naoki, Hayashi, Masamichi, Kobayashi, Daisuke, Tanaka, Chie, Yamada, Suguru, Fujii, Tsutomu, Nakayama, Goro, Sugimoto, Hiroyuki, Koike, Masahiko, Fujiwara, Michitaka, Kodera, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924669/ https://www.ncbi.nlm.nih.gov/pubmed/26872374 http://dx.doi.org/10.18632/oncotarget.7269 |
Ejemplares similares
-
The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy
por: Shimizu, Dai, et al.
Publicado: (2017) -
Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter
por: Yamada, Suguru, et al.
Publicado: (2016) -
Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis
por: Inokawa, Yoshikuni, et al.
Publicado: (2013) -
GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer
por: Shimizu, Dai, et al.
Publicado: (2017) -
Short-term outcomes after conventional transthoracic esophagectomy
por: Niwa, Yukiko, et al.
Publicado: (2016)